Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 12, Issue -, Pages 3175-3189
Publisher
Informa UK Limited
Online
2020-05-06
DOI
10.2147/cmar.s232752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
- (2020) A. Hochhaus et al. LEUKEMIA
- Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities
- (2020) Crescenzio Francesco Minervini et al. Frontiers in Genetics
- Treatment-Free Remission in CML: the US Perspective
- (2019) Guru Subramanian Guru Murthy et al. Current Hematologic Malignancy Reports
- Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
- (2019) Simona Bernardi et al. Cancer Medicine
- Evaluation of residual disease and TKI duration are predictive factors for molecular recurrence after stopping Imatinib first-line in chronic phase CML Patients
- (2019) Franck Emmanuel Nicolini et al. CLINICAL CANCER RESEARCH
- Large amplicon droplet digital PCR for DNA‐based monitoring of pediatric chronic myeloid leukaemia
- (2019) Manuela Krumbholz et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Leukemia‐derived exosomes: Bringing oncogenic signals to blood cells
- (2019) Hossein Sharifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chronic Myeloid Leukaemia: The dangers of not knowing your BCR-ABL1 transcript
- (2019) Kirsty Sharplin et al. LEUKEMIA RESEARCH
- Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
- (2019) Barbara Izzo et al. Frontiers in Oncology
- Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
- (2019) Ilaria Del Giudice et al. Frontiers in Oncology
- Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia
- (2019) Simona Bernardi et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
- (2019) Simona Soverini et al. BLOOD
- A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients
- (2019) M. Isabel Prieto-Conde et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia
- (2019) Georg-Nikolaus Franke et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia
- (2019) Cumbo et al. Genes
- Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
- (2018) Ehab Atallah et al. BMC CANCER
- Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre
- (2018) Ya-Zhen Qin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression
- (2018) Wen-Jun Wang et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan
- (2018) Naoto Takahashi et al. HAEMATOLOGICA
- BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
- (2018) Ilaria S Pagani et al. HAEMATOLOGICA
- Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia
- (2018) Nicoletta Coccaro et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- New rapid method to detect BCR-ABL fusion genes with multiplex RT-qPCR in one-tube at a time
- (2018) Yong-Qing Tong et al. LEUKEMIA RESEARCH
- Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia
- (2018) Massimo Breccia et al. Current Oncology Reports
- Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patients
- (2018) Cosimo Cumbo et al. Oncotarget
- Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan
- (2018) Naoto Takahashi et al. HAEMATOLOGICA
- BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
- (2018) Ilaria S Pagani et al. HAEMATOLOGICA
- Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission
- (2018) Monica Bocchia et al. Frontiers in Oncology
- A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
- (2018) Dorota Link-Lenczowska et al. ANNALS OF HEMATOLOGY
- Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
- (2018) Jerald P. Radich et al. Journal of the National Comprehensive Cancer Network
- Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia
- (2018) Paola Orsini et al. Scientific Reports
- Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors
- (2018) Jorge Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- Is DNA a better assay for residual disease in chronic myeloid leukemia?
- (2018) Jerald Radich HAEMATOLOGICA
- The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
- (2018) Sara Galimberti et al. Frontiers in Oncology
- Mutational analysis in BCR - ABL1 positive leukemia by deep sequencing based on nanopore MinION technology
- (2017) Crescenzio F. Minervini et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia
- (2017) Ilaria S. Pagani et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia
- (2017) Claudia Brunetti et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
- (2017) A Hochhaus et al. LEUKEMIA
- Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
- (2017) R Hehlmann et al. LEUKEMIA
- A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD)
- (2017) M.-H. Duan et al. LEUKEMIA RESEARCH
- Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
- (2017) Alice Giustacchini et al. NATURE MEDICINE
- Remembrance of things past — discontinuation of second-generation TKI therapy for CML
- (2017) Timothy P. Hughes et al. Nature Reviews Clinical Oncology
- Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
- (2017) Mohamed El Missiry et al. PLoS One
- A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia
- (2017) Valentín García-Gutiérrez et al. PLoS One
- Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
- (2017) Liza Löf et al. Scientific Reports
- Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots
- (2016) O. Sala Torra et al. BLOOD
- Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
- (2016) Delphine Rea et al. BLOOD
- Moving treatment-free remission into mainstream clinical practice in CML
- (2016) Timothy P. Hughes et al. BLOOD
- Attomolar electrochemical detection of the BCR/ABL fusion gene based on an amplifying self-signal metal nanoparticle-conducting polymer hybrid composite
- (2016) Karen Y.P.S. Avelino et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing
- (2016) Crescenzio Francesco Minervini et al. Diagnostic Pathology
- Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
- (2016) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients
- (2016) Mary Alikian et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
- (2016) Jinheng Wang et al. JOURNAL OF PATHOLOGY
- NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
- (2016) Arnel Pallera et al. Journal of the National Comprehensive Cancer Network
- Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
- (2016) A Hochhaus et al. LEUKEMIA
- Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
- (2016) Gareth Gerrard et al. LEUKEMIA RESEARCH
- Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis
- (2016) Anna Wojtuszkiewicz et al. MOLECULAR & CELLULAR PROTEOMICS
- Best Practices in Chronic Myeloid Leukemia Monitoring and Management
- (2016) Simona Soverini et al. ONCOLOGIST
- Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients
- (2016) Simona Soverini et al. Oncotarget
- Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects
- (2016) Martin Culen et al. Oncotarget
- Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group
- (2015) Noriyoshi Iriyama et al. AMERICAN JOURNAL OF HEMATOLOGY
- Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
- (2015) Silvia Mori et al. AMERICAN JOURNAL OF HEMATOLOGY
- A review of the European LeukemiaNet recommendations for the management of CML
- (2015) Michele Baccarani et al. ANNALS OF HEMATOLOGY
- Natural course and biology of CML
- (2015) Bradley Chereda et al. ANNALS OF HEMATOLOGY
- Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
- (2015) Y.-Y. Yeh et al. BLOOD
- A DNA Real-Time Quantitative PCR Method Suitable for Routine Monitoring of Low Levels of Minimal Residual Disease in Chronic Myeloid Leukemia
- (2015) Paul A. Bartley et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells
- (2015) L Mourgues et al. LEUKEMIA
- Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
- (2015) N C P Cross et al. LEUKEMIA
- Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing
- (2015) Jana Linhartova et al. Molecular Cancer
- A longitudinal evaluation of performance of automated BCR-ABL1 quantitation using cartridge-based detection system
- (2015) Anoop Enjeti et al. PATHOLOGY
- BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR
- (2015) Antonella Zagaria et al. VIRCHOWS ARCHIV
- Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
- (2015) Jun Imagawa et al. Lancet Haematology
- Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
- (2014) H. Herrmann et al. BLOOD
- Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline
- (2014) S. Branford et al. BLOOD
- How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia
- (2014) David M. Ross et al. BRITISH JOURNAL OF HAEMATOLOGY
- DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia
- (2014) Peter Valent et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
- (2014) Henrik Hjorth-Hansen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Minimal residual disease testing in hematologic malignancies and solid cancer
- (2014) Amin Ben Lassoued et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR
- (2014) Lawrence J. Jennings et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
- (2014) H White et al. LEUKEMIA
- Transferred BCR/ABL DNA from K562 Extracellular Vesicles Causes Chronic Myeloid Leukemia in Immunodeficient Mice
- (2014) Jin Cai et al. PLoS One
- Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
- (2014) Junko Ohyashiki et al. Drug Design Development and Therapy
- Extracellular Vesicles as Shuttles of Tumor Biomarkers and Anti-Tumor Drugs
- (2014) Davide Zocco et al. Frontiers in Oncology
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
- (2013) D. M. Ross et al. BLOOD
- Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale
- (2013) H. E. White et al. CLINICAL CHEMISTRY
- Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease
- (2013) Philippe Rousselot et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib 300mg BID as frontline treatment of CML: Prospective analysis of the Xpert BCR-ABL Monitor system and significance of 3-month molecular response
- (2013) Michael E. O’Dwyer et al. LEUKEMIA RESEARCH
- Absolute quantification by droplet digital PCR versus analog real-time PCR
- (2013) Christopher M Hindson et al. NATURE METHODS
- Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns
- (2012) C. E. López-Jorge et al. ANNALS OF HEMATOLOGY
- Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
- (2012) Manuela Krumbholz et al. GENES CHROMOSOMES & CANCER
- Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors
- (2012) A. R. Rossi et al. HAEMATOLOGICA
- Standardized definitions of molecular response in chronic myeloid leukemia
- (2012) N C P Cross et al. LEUKEMIA
- Digital PCR hits its stride
- (2012) Monya Baker NATURE METHODS
- Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation
- (2012) Alexandra S. Whale et al. NUCLEIC ACIDS RESEARCH
- Concomitant occurrence of BCR-ABL and JAK2V617F mutation
- (2011) L. Pieri et al. BLOOD
- Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease
- (2011) J.-C. Chomel et al. BLOOD
- Sensitive DNA impedance biosensor for detection of cancer, chronic lymphocytic leukemia, based on gold nanoparticles/gold modified electrode
- (2011) Ali A. Ensafi et al. ELECTROCHIMICA ACTA
- Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
- (2011) David Marin et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array
- (2011) Wu Yujie et al. LEUKEMIA & LYMPHOMA
- Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay
- (2011) Hyun-Gyung Goh et al. LEUKEMIA & LYMPHOMA
- Decreased TET2 gene expression during chronic myeloid leukemia progression
- (2011) F. Albano et al. LEUKEMIA RESEARCH
- The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
- (2010) Rajesh R. Nair et al. BIOCHEMICAL PHARMACOLOGY
- BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
- (2010) A. Rizo et al. BLOOD
- Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia
- (2010) Paul A. Bartley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA
- (2010) P. A. BARTLEY et al. International Journal of Laboratory Hematology
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Analysis of genomic breakpoints in p190 and p210 BCR–ABL indicate distinct mechanisms of formation
- (2010) J Score et al. LEUKEMIA
- Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR
- (2010) D M Ross et al. LEUKEMIA
- Standardisation of molecular monitoring for chronic myeloid leukaemia
- (2009) Nicholas C.P. Cross BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia
- (2009) S. Raponi et al. HAEMATOLOGICA
- Molecular Monitoring of Residual Disease in Chronic Myeloid Leukemia by Genomic DNA Compared with Conventional mRNA Analysis
- (2009) Elia Mattarucchi et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Flow cytometric immunobead assay for the detection of BCR–ABL fusion proteins in leukemia patients
- (2009) F Weerkamp et al. LEUKEMIA
- Electrochemical Biosensor for Detection of BCR/ABL Fusion Gene Using Locked Nucleic Acids on 4-Aminobenzenesulfonic Acid-Modified Glassy Carbon Electrode
- (2008) Jinghua Chen et al. ANALYTICAL CHEMISTRY
- Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
- (2008) S. Branford et al. BLOOD
- Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia
- (2008) Elia Mattarucchi et al. GENES CHROMOSOMES & CANCER
- Proteomic profiling of exosomes: Current perspectives
- (2008) Richard J. Simpson et al. PROTEOMICS
- A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts
- (2007) Thomas Burmeister et al. LEUKEMIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started